-
News | 2024.03.25
Tackling flaviviruses and preparing the European Union for emerging threats
The genus flavivirus includes several human pathogens, such as Zika, dengue, West Nile virus (WNV) and yellow fever virus, which persist as major threats to global public health. Yellow4FLAVI, coordinated by Giovanna Barba-Spaeth, Institut Pasteur, comprises 13 partner institutions and is supported by the European Union with with € 8 million. The aim is to use the 17D yellow fever vaccine as...
-
Article | 2019.08.06
Vaccinology and Immunotherapy Initiative: Fundamental Research
Many different fields of the highly recognized fundamental research pursued at the Institut Pasteur are connected to vaccinology or immunotherapy. These include pathogen identification and characterization, structural analysis, in silico approaches, analysis of mechanisms to potentially enhance antigen immunogenicity and/or delivery or to identify specific immunotherapy targets, effects of...
-
Document de presse | 2006.10.25
Pertussis is still with us!
Whooping cough or pertussis is still the primary cause of death by bacterial infection in infants less than two months old, in France despite general vaccination. The endemicity of this infection is observed in many vaccinated countries. The agent of the disease, a bacterium, was isolated by the Pasteur scientist, Jules Bordet(1) in 1906. For this centenial, the Institut Pasteur is co-organising...
-
Fiche maladie | 2015.10.06
Whooping cough (pertussis)
Whooping cough, long thought of as a childhood illness, can be severe at any age. This bacterial infection is particularly dangerous, and sometimes even fatal, for unvaccinated or partially vaccinated infants and at-risk individuals such as pregnant women and elderly people.
-
News | 2024.11.25
Four New Pasteur Courses to Boost Your Expertise
The Institut Pasteur is offering four new specialized courses for professionals and students eager to expand their knowledge in critical areas of health science. With urgent global challenges such as climate change, emerging infectious diseases, and maternal and child health, these courses provide the expertise needed to address today’s most pressing issues.Explore key topics such as climate...
-
Document de presse | 2016.07.18
Malaria: a genetically attenuated parasite induces an effective, long-lasting immune response
With nearly 3.2 billion people currently at risk of contracting malaria, scientists from the Institut Pasteur, the CNRS and Inserm have experimentally developed a live, genetically attenuated vaccine for Plasmodium, the parasite responsible for the disease. By identifying and deleting one of the parasite's genes, the scientists enabled it to induce an effective, long-lasting immune response...
-
News | 2016.11.30
3rd Institut Pasteur International Network Symposium celebrates Biomarkers
The opening ceremony of the Institut Pasteur International Network Symposium held on 29th of November at the Institut Pasteur Conference Center gathered nearly 350 participants. Building on the success of the two previous editions, the Symposium focuses this year on all research aspects that might potentially lead to the development of new biomarkers.In his opening speech, Christian Brechot,...
-
Vidéo | 2025.04.07
The comeback of measles
Measles explodes in 2025: what do we do?Nearly 200 cases in France this year, twice as many as last year! This ultra-contagious virus infects the respiratory tract before spreading throughout the body. 1 patient can infect 20 - as easily as a cold! Fever, cough, rash... but above all serious complications for 1 in 5 people: pneumonia, encephalitis, hospitalization, and babies at risk. Over a...
-
News | 2016.07.17
Malaria: a genetically attenuated parasite induces an effective, long-lasting immune response
With nearly 3.2 billion people currently at risk of contracting malaria, scientists from the Institut Pasteur, the CNRS and Inserm have experimentally developed a live, genetically attenuated vaccine for Plasmodium, the parasite responsible for the disease. By identifying and deleting one of the parasite's genes, the scientists enabled it to induce an effective, long-lasting immune response...
-
News | 2015.01.26
Patronage: the Institut Pasteur and the Total Foundation renew their common commitment against infectious diseases
For 10 years, Total and its corporate foundation working alongside the Institut Pasteur and its International Network in the fight against infectious diseases. A new sponsorship agreement, of EUR 6 million for three years, was signed on 26 January 2015. It will provide funding, for public health and research projects in resource limited countries in order to better understand the therapeutic and...